Results 271 to 280 of about 196,164 (338)

A 50‐year‐old man with a 12‐year history of extensive pachymeningeal thickening

Brain Pathology, EarlyView.
Alyssa M. Lee, Siddhartha Gaddamanugu, Kathyrn L. Eschbacher, Aishwarya Ravindran   +3 more
wiley   +1 more source

Polatuzumab vedotin-R-CHP used for high-risk EBV-negative DLBCL-type post-transplant lymphoproliferative disorder in a long-term kidney transplant recipient: a case report. [PDF]

Front Oncol
Jiang X, Wu C, Zhang YO, Luo M, Qiu Y, Li M, Zhan L, Zhong D.   +7 more
europepmc   +1 more source

Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies

European Journal of Haematology, EarlyView.
ABSTRACT Hematologic malignancies represent the most common cancers in children. While the mainstays of treatment are chemotherapy and potentially hematopoietic stem cell transplant, minimally invasive surgery (MIS) has a role in the diagnosis and management of complications related both to disease and therapy as well as common pediatric surgical ...
Alejandro Chara, Katlyn G. McKay, Harold N. Lovvorn III, Joseph C. Fusco   +3 more
wiley   +1 more source

Long-term real-world outcomes of rituximab in primary membranous nephropathy: a 154-patient cohort study from China. [PDF]

Ren Fail
Qi Y, Cao X, Gao XQ, Cheng X, Fang YX, Zhang XX, Zheng ZF, Wei L, Shang WY, Jia JY, Yan TK, Xu PC, Gu QH.   +12 more
europepmc   +1 more source

Sutimlimab in Patients With Cold Agglutinin Disease (CAD): Results From a Managed Access Program

European Journal of Haematology, EarlyView.
ABSTRACT Cold agglutinin disease (CAD) is a low‐grade lymphoproliferative disorder accounting for 15%–30% of patients suffering from autoimmune hemolytic anemias. The clonal B cells produce autoantibodies primarily of the IgM‐κ class that cause agglutination of red blood cells (RBCs) at temperatures ≤ 37°C and activate the classical complement pathway ...
Sandra Maria Frey, Pauline Halberstadt, Ferras Alashkar, Veronika Lenz, H. Christian Reinhardt, Alexander Röth   +5 more
wiley   +1 more source

Three-Year Diagnostic Delay in Shrinking Lung Syndrome: Rituximab-Theophylline Combination as Rescue Therapy. [PDF]

Respirol Case Rep
Motamed S, Mirzamohamadi A, Sadeghi S, Ardestani Rostami V, Mahalleh M, Alikhani M.   +5 more
europepmc   +1 more source

Frontline Therapy in Diffuse Large B‐Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions

European Journal of Haematology, EarlyView.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) remains the most common aggressive lymphoma, representing a biologically heterogeneous disease with diverse clinical behaviors. For more than two decades, R‐CHOP has been the cornerstone of frontline treatment, curing approximately two‐thirds of patients.
Mamdouh Skafi, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Maria Eugenia Alvaro, Fortunato Morabito, Enrica Antonia Martino, Massimo Gentile   +12 more
wiley   +1 more source

Impact of Rituximab Maintenance on outcomes in Follicular Lymphoma: An indian experience. [PDF]

Leuk Res Rep
Pant H, Gogia A, Sharma A, Wig N, Raju Sagiraju HK, Mallick S, Gupta R, Biswas A.   +7 more
europepmc   +1 more source

Quality of life over time after new onset refractory status epilepticus

Epilepsia, EarlyView.
Abstract Objective This study aims to better characterize the long‐term neurological quality of life (QOL) outcomes (using the Neuro‐QOL scale) in survivors of new onset refractory status epilepticus (NORSE), including its subtype febrile infection‐related epilepsy syndrome (FIRES), and provide guidance for psychological and social support strategies ...
Matthew D. Gruen, Margaret T. Gopaul, Anthony D. Jimenez, Ayush Batra, Leah J. Blank, Charlotte Damien, Gregory S. Day, Krista Eschbach, Elizabeth E. Gerard, Teneille E. Gofton, Stephen T. Hantus, Nathalie Jette, Amy Jongeling, Peter Kang, Karnig Kazazian, Marissa Kellogg, Minjee Kim, Bahar Madani, Mikaela Morales, Vineet Punia, Claude Steriade, Aaron Struck, Olga Taraschenko, Nathan Torcida, Mark S. Wainwright, Ji Yeoun Yoo, Nicolas Gaspard, Nora Wong, Lawrence J. Hirsch, Aurélie Hanin   +29 more
wiley   +1 more source

Selinexor combined with R-GDP as salvage therapy in relapsed/refractory diffuse large B-cell lymphoma. [PDF]

Am J Cancer Res
Jiang S, Li Y, Liu C, Liu Y, Zhang Q, Lv F, Zhang W.   +6 more
europepmc   +1 more source